Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1976-09-13
1978-04-11
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
195 11, 195 13, 195 17, A61K 3912
Patent
active
040839583
ABSTRACT:
An inactivated viral vaccine for protecting horses against disease caused by equine rhinopneumonitis virus is prepared by propagating an equine rhinopneumonitis virus in a susceptible, cloned, diploid equine cell line, harvesting the resulting virus in a serum-free medium, inactivating the virus and neutralizing the inactivating agent, concentrating the virus, and adding an immunological adjuvant thereto. A vaccination program to protect horses against the equine rhinopneumonitis virus is also disclosed.
REFERENCES:
vet. Bull. 46 (1976) #633-#637, #1305-#1306, #2452 #2453.
Vet. Bull. 45 (1975) #951, #1633-#1635, #4957 #4958.
Vet. Bull. 44 (1974) #1546-#1547, #5445.
Vet. Bull. 42 (1973) #2453, #3834, #4568, #6262, #6850.
Rose Shep K.
The University of Kentucky Research Foundation
LandOfFree
Inactivated equine rhinopneumonitis virus vaccine and use thereo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivated equine rhinopneumonitis virus vaccine and use thereo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivated equine rhinopneumonitis virus vaccine and use thereo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-989442